Five of the genes for the biosynthesis of isoleucine and valine form the ilvGMEDA operon of Escherichia coli K-12. Expression of the operon responds to changes in the availability of isoleucine, leucine, and valine (ILV). Addition of an excess of all three amino acids results in reduced expression of the operon, whereas limitation for one of the three amino acids causes an increase in expression. The operon is preceded by a leader-attenuator which clearly regulates the increased expression that occurs due to reduced aminoacylation of tRNA. To assess the factors that result in the reduced expression of this operon upon the addition of ILV, a series of plasmids were constructed in which the ilv regulatory region was fused to galK. In response to addition of the amino acids, expression of the galK gene fused to the leader-attenuator decreased five-to sevenfold, instead of the twofold observed for the chromosomal operon. A deletion analysis with these plasmids indicated that the ILV-specific decrease in expression required an intact leader-attenuator but not ilvGp2 or the DNA that precedes this promoter. This conclusion was supported by both Sl nuclease analysis of transcription initiation and determination of galK mRNA levels by RNA-RNA hybridization.
Wild-type Escherichia coli K-12 can synthesize all its molecular components when grown on a minimal salts medium containing suitable carbon and nitrogen sources. During steady-state or exponential growth, the cells presumably synthesize the appropriate quantity of each metabolite so as to achieve optimal growth. This is facilitated by the ability of the cell to increase or decrease the synthesis of enzymes or alter the catalytic activity of specific enzymes in response to changes in the environment in which the cell is growing. For several amino acid-biosynthetic systems, the cell responds to an exogenous source of an amino acid (i.e., an excess) by decreasing (i.e., repressing) the expression of the relevant genes. Alternatively, if the amount of an amino acid becomes growth limiting (i.e., starvation), the bacteria will increase expression of the genes required for the biosynthesis of that amino acid.
The trp operon is probably the most thoroughly studied set of genes for the biosynthesis of an amino acid. For the trp operon, the molecular mechanisms (34, 50) that result in the change in expression of this operon in response to either an excess or limitation for tryptophan are distinct. The trp repressor protein regulates the operon by mediating the initiation of transcription by RNA polymerase (RNAP) in response to an excess of free tryptophan within the cell.
When growth is limited by tryptophan, increased expression of the operon occurs as a result of reduced aminoacylation of trp tRNA. This change in trp operon expression is mediated by the leader-attenuator. As described by Yanofsky et al. (50) , the combination of the repressor-operator and the leader-attenuator results in a 500-to 600-fold range in expression of the trp operon.
The ilvGMEDA operon encodes four of the enzymes for the biosynthesis of the branched-chain amino acids isoleucine, leucine, and valine (ILV) (26) . These genes are multivalently regulated by all three amino acids, i.e., repression of the operon requires the presence of all three amino acids, while growth limitation for any one of the three results in an * Corresponding author. increase in expression of the operon (11) . No regulatory protein has been identified that modulates expression of the operon in response to changes in the availability of the three amino acids. A leader-attenuator precedes the structural genes, and the proposed leader peptide includes residues of all three amino acids, consistent with the multivalent regulation of the operon (2, 25, 26, 35) . The data accumulated for the response of this operon to amino acid limitation are consistent with its being mediated via the leader-attenuator (26) . Using an ilvD-lacZ fusion, Bennett and Umbarger (4) isolated a pair of deletions that extended into the leaderattenuator. Their results indicate that the leader-attenuator sequences participate in changes in operon expression in response to either a limitation for one or an excess of all three amino acids. Clearly, limitation for an amino acid results in a decrease in aminoacylation of the cognate tRNAs. Both theoretical (30, 46, 47) and experimental (reviewed in reference 20) analyses indicate that reduced transcription termination at an attenuator requires a relatively large change in the level of aminoacylation. This contrasts with the response of an E. coli wild type grown on minimal medium to which the three branched-chain amino acids are added. In minimal medium, the level of aminoacylation is very high (approaching 100% in some studies); therefore, it seems unlikely that the addition of ILV will dramatically alter the level of aminoacylation. If both the analyses of attenuation and the assumption that tRNA is not limiting (quality, aminoacylation, etc.) are correct, then the question arises of how repression is mediated by the leaderattenuator of the ilvGMEDA operon. This seems to imply that the decrease in gene expression must result from subtler changes affecting the attenuator than are required for increased expression.
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Identical to pRL137 except for the 21 mutation ilvGA951, G --A transition at bp 177 ( Fig. 1 ) pMW333
Identical to pRL137 except for the 21 mutation ilvGe952, T --C transition at bp 34 ( Fig. 1) initiation but occurs at the leader-attenuator. The addition of all three amino acids to minimal medium results in a five-to sevenfold reduction of galactokinase expression when the galK gene is fused to the ilv regulatory region. Furthermore, analysis of both the initiation of RNA synthesis and steadystate levels of galK mRNA indicate that the decrease in gene expression is mediated by the leader-attenuator. Thus, unlike the trp operon, one mechanism (attenuation) serves to modulate expression of the ilvGMEDA operon in response to either an excess of the amino acids or limitation for one of them.
MATERIALS AND METHODS
Bacteria, plasmids, and medium. The E. coli K-12 strain used in this study was M152 [galK2 recA3 rpsL200 IN(rrnDrrnE)I], which was obtained from the E. coli Genetic Stock Center. Plasmid pT7/T3-18 was obtained from Bethesda Research Laboratories, Inc., and the other plasmids used in this study are described in Table 1 (with reference to Fig. 1 ). M63 minimal medium was prepared as described by Miller (32) and contained ampicillin (100 ,ug/ml). The amino acids isoleucine and leucine were added to a final concentration of 0.5 mM, while the concentration of valine was 1.0 mM. (37) . Threonine deaminase was assayed as described by Lawther and Hatfield (24) , in an assay that measures the conversion of threonine to aketobutyrate by reaction with 2,4-dinitrophenylhydrazine. Specific activities are the average of at least three independent assays of each plasmid construct. Protein was determined by the method of Bradford (5) with a reagent obtained from Bio-Rad Laboratories.
Quantitation of transcription initiation by Si nuclease analysis. Cellular RNA was prepared as described by Salser et al. (43) . The RNA concentration was determined by measuring the A260. The 416-base-pair (bp) BstNI restriction fragment (from -356 to +60 bp, Fig. 1 ) was isolated by standard procedures. The DNA fragment was 5'-end labeled with T4 polynucleotide kinase and then treated with exonuclease III to generate single-stranded probe (28, 33) . The DNA probe was hybridized with cellular RNA and treated with Si nuclease as previously described (28) . The products of the Si digestion were resolved by electrophoresis on an 8 M urea-20% polyacrylamide gel, visualized by autoradiography, and quantitated by densitometric analysis.
Quantitation of gaLK-specific mRNA by RNA dot blot hybridization. To generate labeled RNA for use as hybridization probes, the pT7/T3-18 derivative pJL286 (Table 1) was transcribed in vitro. The vector plasmid insert resides between the T7 and T3 bacteriophage promoters, and thus complementary hybridization probes can be generated. To yield RNA complementary only to the insert, the plasmid was linearized by digestion with the appropriate restriction endonuclease. Transcription reactions were conducted in vitro in a 10-.lI volume at 37°C for 1 h. Each reaction mix contained 250 ng of template DNA, 5 mM dithiothreitol, 400 ,M each ATP, GTP, and CTP, 10 ,uM [a-32P]UTP (specific activity, 800 Ci/mmol), the reaction buffer [40 mM Tris hydrochloride (pH 8.0), 8 mM MgCl2, 25 mM NaCl, 2 mM spermidine-(HCl)3], and 20 U of either T7 or T3 RNAP. The reactions were terminated by the addition of 1 ,ul of 100 mM EDTA. The RNA products were precipitated from 0.3 M sodium acetate (pH 5.5) with 2.5 volumes of 100% ethanol by incubating in a dry ice-ethanol bath for 20 min. The RNA was then collected by centrifugation in a microcentrifuge (15,000 x g, 15 min).
Cellular RNA was filtered onto Nytran with a Schleicher & Schuell Minifold filtration apparatus. Two sheets of dry 3MM Whatman filter paper placed underneath the Nytran served to draw the nucleic acid solution by capillary action through the Nytran that was preequilibrated with 6x SSPE (20x SSPE is 3 M NaCl, 20 mM EDTA, 0.2 M NaPO4 [pH 7.7] ). RNA was denatured in 100 p,l of filter-sterilized 6% formaldehyde-30 mM NaPO4 (pH 6.8)-i M NaCl by incubating at 65-C for 5 min. Once denatured, the RNA was immediately filtered onto the membrane, the apparatus was disassembled, and the blot was soaked in 6x SSPE until the aroma of the formaldehyde could no longer be detected. The blots were annealed in vacuo at 80°C for 2 h and stored at room temperature.
Prehybridization of the filter was accomplished by over- Fig. 1 ). Each plasmid was transfected into M152 (galK2), and the specific activity of galactokinase was determined for cells grown in M63 minimal medium in the absence or presence of ILV. This analysis indicated that the ILV-modulated decrease in expression required the sequences that include the ilvGMEDA leaderattenuator.
As described previously (1, 26, 37) , the DNA sequences upstream of the site for the initiation of transcription in vivo (ilvGp2, Fig. 1 ) enhance transcription from ilvGp2 by roughly eightfold. This is evidenced in Fig. 1 by a comparison of the specific activity of galactokinase for M152 transfected with pMO139 compared with that for M152 containing pRL137 (deletion of upstream DNA). Because these DNA sequences influence expression from ilvGp2, it is possible that they are involved in the amino acid-specific regulation of the operon. The data in Fig. 1 demonstrate that the DNA upstream of ilvGp2 did not serve a role in amino acid-specific regulation. A similar reduction in the specific activity of galactokinase was observed for both pRL137-and pMO139-containing bacteria upon the addition of ILV (Fig. 1) . Because the upstream region was not involved in amino acid-mediated regulation, it was not included in any subsequent plasmid constructs. Comparison of the decrease in expression of galactokinase from pRL137 with that from pKB212 indicated that the decrease in expression (upon the addition of ILV) did not require the DNA sequences downstream of the ilv attenuator (ilvGa). The reduced expression observed from the plasmid pKB212 relative to that from pRL137 was a translational effect (i.e., polar), on galK expression due to the deletion of the ilvG translation initiation site. This conclusion is based upon the results of inserting into pKB212 an oligonucleotide that included the ilvG translation initiation site (R. P. Lawther and K. Bell, unpublished observations). Thus, comparison of galactokinase expression from the plasmids pMO139, pRL137, and pKB212 indicates that the reduced expression upon the addition of ILV requires sequences that include ilvGp2 through the attenuator.
The absence of ILV repression of galactokinase expression from the plasmids pMO167 and pRL149 demonstrates that ILV-specific regulation requires an intact ilv regulatory region (Fig. 1) . Plasmid pMO167 contains a restriction fragment that includes ilvGp2 through the carboxy terminus of the leader peptide. Expression of galactokinase from this plasmid was unaffected by the addition of ILV to the medium. Plasmid pRL149 was constructed from plasmid pDR720 by inserting the attenuator (i.e., terminator), ilvGa, downstream of the trp promoter (trpEp). As shown in Fig. 1 , the presence of ILV had no effect on expression of galactokinase from pRL149. Galactokinase expression from plasmid pCR276 demonstrated that ilvGp2 was not required for ILV-specific regulation (Fig. 1) . This plasmid was constructed by inserting a fragment from + 10 through +645 bp Analysis of the regulation of galK expression from the two plasmids pDM287 and pMW333 (containing point mutations [21] ) further supports the role of the leader-attenuator in ILV-specific repression. The stem of the attenuator, ilvGa, contains five contiguous G residues. In plasmid pDM287, the central G has been replaced by an A (ilvGa9Sl), which reduces the stability of the attenuator (21) . The unrepressed level of galactokinase for pDM287 was identical to that for pMO167, in which the attenuator is totally absent. Plasmid pMW333 contains a mutation (ilvGe952) of the initiation codon for the leader peptide, changing the AUG codon to ACG. For each of these plasmids there was slightly less than a twofold effect on expression after the addition of ILV. For pMW333, the low level of expression that remained after the translation initiation codon was altered (AUG to ACG) has in the case of other operons been ascribed to a continued low level of translation initiation (20) . The reduction of expression from pDM287 upon the addition of ILV appears to indicate that substitution of A for G in the stem of the attenuator limits its effectiveness as a terminator but that under repressing conditions it retains some effectiveness as a terminator of transcription.
Analysis for deattenuation. Previous studies of the effect of the addition of ILV on gene expression have usually assayed transaminase B (ilvE) and threonine deaminase (ilvA), the third and fifth genes of the operon, respectively (23) . Those studies demonstrated two-to threefold ILV repression of the operon. Therefore, the possibility existed that the five-to sevenfold decrease observed with the ilv-galK fusions was the result of a combination of the two aspects of ILV-specific regulation of the ilvGMEDA operon. Thus, the five-to sevenfold differential would be due to both the effect of an excess of the three amino acids (i.e., the twofold repression observed for the chromosomal operon) and, in part, a limitation for one of the three amino acids (because of the presence of the plasmids) causing reduced transcription termination of the attenuator. Whether a limitation for isoleucine, leucine, or valine explains why the repression of the ilv-galK fusions was greater than expected (i.e., fivefold instead of twofold) was examined by two approaches. If the specific activity of galactokinase observed in the absence of ILV is the function of a limitation for one of the three amino acids or an aminoacylated tRNA, then the effect should occur in trans and expression of the ilvGMEDA operon should increase. The specific activity of threonine deaminase in M152 grown on unsupplemented minimal medium was 95 nmol/min per mg of protein, and the introduction of either the parental vector pKO6 or the plasmid pRL137 did not alter the specific activity of threonine deaminase (specific activities of 99 and 95 nmol/min, respectively). Additionally, the response of threonine deaminase to the presence of an excess of ILV or limitation for one of the branched-chain amino acids was unaffected by the presence of the plasmids (data not shown). Together, these observations indicate that amino acid limitation (caused by the introduction of plasmids) does not explain the five-to sevenfold effect on galK expression.
As an alternative to the analysis of threonine deaminase, the ilv-galK fusions were introduced as single-copy DNA into M152. This was achieved by using X65 a derivative of Xgt4 (9) into which npt (the gene for kanamycin resistance from transposon TnS) and galK had been introduced. The bacteriophage (X65) was constructed with the npt and galK genes adjacent to one another but oriented in opposite directions without promoters (i.e., npt-, galK-). To facilitate the transfer of an ilv-galK construct from a plasmid to X65, a functional npt gene was inserted into the plasmid in opposite orientation to galK by using a BamHI cassette. The ilv-galK fusions were then transferred to the virus by homologous recombination between the npt and galK genes of the virus and the plasmid. The recombined viral product was retrieved from lysates by selection of kanamycin-resistant lysogens of M152. 'The virus was purified by standard techniques (9) , and the structures of the bacteriophage and their lysogens were analyzed by digestion with restriction endonucleases (R. Pereira and R. P. Lawther, unpublished observations). M152 was lysogenized with the viruses corresponding to the plasmid vector (X65, i.e., no promoter preceding galK), pRL137 (X250), and pMO167 (X305). The lysogenized bacteria were grown in M63 medium with and without the addition of ILV. The addition of ILV resulted in about an eightfold decrease in galK expression when it was fused to an intact leader-attenu'ator (X250), whereas the addition of ILV had little effect if the attenuator was deleted (X305) ( Table 2) . These results further support the plasmid analysis results and indicate not only that the degree of repression is not due to an amino acid limitation but also that it is not a function of the overall structure, conformation, or copy number of the plasmids. Analysis of transcription initiation from ilvGp2. The data obtained by analysis of galactokinase expression are most consistent with ILV regulation being' modulated via the leader-attenuator. To determine whether this regulation is attenuator-modulated requires knowing whether transcription initiation remains unchanged relative to the level of galK expression. To achieve this, transcription initiation was quantitated by Si nuclease analysis. The 416-bp BstNI restriction fragment', from' -356 bp upstream to 60 bp downstream of the in vivo transcription initiation site (Fig.  1 measured by using Si nuclease to quantitate the 5' terminus of the RNA (Table 3) . Since the product of Si digestion corresponded to the previously determined 5' terminus of the ilv leader RNA (2, 37), it seems reasonable to conclude that the Si analysis measures initiation. The addition of ILV caused a fivefold decrease in the specific activity of galactokinase in M152 containing pRL137, while galK expression originating from pMO167 was unaffected. However, the ratio of transcription initiation without and with ILV (-ILV/ +ILV) for galK (as measured by Si nuclease analysis) was roughly 1.2 for both plasmids. Similarly, the attenuator mutation ilvGa951 (pDM287) yielded the same ratio. Thus, analysis of the initiation of transcription results is consistent with the analysis of galactokinase activity results, i.e., repression is not mediated at transcription initiation. Quantitation of gaLh-specfiic mRNA. As described above, the data presented for the expression of the ilv-galK fusions indicate that the ILV-specific decrease in gene expression is modulated through the leader-attenuator. If the decrease in expression reflects alterations in transcription downstream of the attenuator, then the quantity of galK mRNA should fluctuate accordingly. Galactokinase mRNA was quantitated by dot blot hybridization. To facilitate this analysis, a unique plasmid was constructed by using the vector pT7iT3-18. A 418-bp AluI restriction fragment that includes DNA sequences encoding the amino-terminal portion of galactokinase was inserted into the BamHI restriction site of pT7/ T3-18 to yield pJL286. The vector contains two promoters on opposite sides of a polylinker. One promoter is only recognized by T3 RNAP, while the second is only recognized by T7 RNAP. Transcription of pJL286 with T3 RNAP yielded an RNA molecule with a sequence identical to that of the galactokinase mRNA. Transcription of the plasmid with T7 RNAP yielded an RNA with a sequence complementary to galactokinase mRNA. T3 and T7 RNAP-directed transcripts were labeled with [_a-32P]UTP. These RNAs were hybridized to Nytran filters spotted with 0.5, 1.0, and 2.0 ,ug of RNA extracted from M152 transfected with the plasmids indicated in Table 4 . The RNA-RNA hybrids were localized by autoradiography, and the radioactivity was determined for each spot by liquid scintillation counting.
No cellular RNA was detected' with the probe generated by using T3 RNAP (sequence identical to galK mRNA). The data obtained with the probe generated by using T7 RNAP (sequence complementary to galK mRNA) are presented in Table 4 . The RNA extracted from M152 transfected with pRL137 indicated that the addition of ILV resulted in nearly a fourfold decrease in galK-specific RNA (a fivefold difference was observed for galactokinase activity, Fig. 1 ). RNA extracted from M152 containing pDM287 showed a twofold difference without and with ILV, similar to the change observed in galactokinase specific activity. RNA extracted from M152 containing pRL149 or pMO167 showed no differences without or with ILV, in agreement with the observations for galactokinase. The result for pMO167 was especially gratifying because the -ILV/+ILV ratio was identical whether transcription initiation (Table 3) or galK mRNA levels (Table 4) were measured. It should also be noted that in the absence of ILV, the trp promotor construct pRL149 yielded approximately one-half the quantity of mRNA obtained from the ilv plasmid (pRL137) but both plasmids yielded similar quantities of galactokinase (compare Table 1 with Table 4 ). This difference may be related to observations made for trpE (8) and the bacteriophage T7 (36) , in which nucleotide sequences upstream of the translation initiation site affect the efficiency of translation of an mRNA.
DISCUSSION
As described in the Introduction, the ilvGMEDA operon responds in two ways to ILV-specific regulation. Limitation for one of the three branched-chain amino acids causes an increase in expression, while the concomitant addition of all three amino acids causes a decrease in expression. Both the structure of the leader-attenuator and the known effect of a decrease in aminoacylation of ILV tRNA indicate that the effect of amino acid limitation is mediated by attenuation.
The data discussed in this report demonstrate that the leader-attenuator also has a functional role in the response of the operon to an excess of the three amino acids. As shown in Fig. 1 , the addition of ILV resulted in a five-to sevenfold decrease in galactokinase activity, and this effect required that the leader-attenuator but not ilvGp2 be intact. The data presented in Table 4 (23) . The analysis of the specific activity of both threonine deaminase and galactokinase (for the ilv-galK fusions inserted into the chromosome, Table 2 ) indicates that this difference does not occur because the plasmid-containing bacteria are limited for aminoacylated tRNA. A further indication that the five-to sevenfold decrease in galK expression caused by ILV is not likely to be due to an alteration of the aminoacylation of isoleucyl-, leucyl-, or valyl-tRNA is that addition of the three amino acids did not alter the rate of growth of M152. This is contrary to the expectation that if the aminoacylation of the tRNA of one of these amino acids was limiting (i.e., resulting in a decrease in attenuation), the rate of growth of the bacteria would be stimulated upon its addition. These observations on the absence of an effect on the rate of growth of the bacteria are consistent with the cells' not being limited for one of the three amino acids, but they do not preclude the possibility that the aminoacylation of the tRNA could be reduced sufficiently to affect attenuation but not the rate of growth of the bacteria. Thus, the observed five-to sevenfold decrease is not due to a combination of limitation for one amino acid and an excess of all three. The limited change in expression observed for the wild-type operon probably results from two aspects of its structural organization. First, as a result of a frameshift site within ilvG, expression of ilvEDA from ilvGp2 is reduced due to polarity (22, 29) . Second, an internal promoter, ilvEp, lies within ilvM (28, 48) and accounts for a substantial fraction of the expression of ilvEDA (29) . Since the effect of the addition of ILV occurs at the leader-attenuator, the combination of polarity on expression from ilvGp2 and the presence of ilvEp limits the extent of the effect of the ILV addition to the distal portion of the operon. Thus, the difference (five-versus twofold) observed in change in gene expression for the ilv-galK fusions versus previous analysis of the chromosomal operon is due to the structure of the wild-type operon.
The subject of this study is the manner or mechanism by which ILV-specific decrease in gene expression occurs. The data presented indicate that the nucleic acid sequences that constitute the leader-attenuator modulate this physiological response. Two obvious models exist, i.e., the binding of an ILV-specific repressor or modulation via attenuation. As discussed, no ILV-specific regulatory protein which accounts for multivalent regulation has been identified, and currently the existence of such a protein seems unlikely. Thus, the most probable mechanism for mediating the effect of an excess of ILV is attenuation. Investigations of the regulation of amino acid biosynthesis demonstrate that several factors can alter the efficiency of attenuation. Besides the physiological state of tRNA (6), these include translation of the leader RNA (20) , the coupling of translation to transcription (20) , and the secondary structure of the leader RNA (20) .
The importance of tRNA in the regulation of amino acid biosynthesis was first indicated by the demonstration that reduced aminoacylation of tRNA caused an increase in gene expression (10) . These observations were extended by the isolation of mutations that caused an increase in the expression of the his operon due to alterations in the metabolism of tRNAH S. Mutant strains (27, 41) demonstrated that expression of the his operon was affected by alteration of (i) the percentage or level of tRNA aminoacylation, (ii) the quantity of tRNA, and (iii) tRNA modification. Presumably, the effect of tRNA on gene expression results from an alteration in the rate of translation of the leader RNA (38) . Changing either the quantity or quality of the tRNA alters the progression of the ribosome relative to RNAP and thus affects leader RNA secondary structure and/or the coupling of transcription with translation of the leader RNA. Our recognition of the importance of the coupling of transcription and translation was confirmed by identification of sites at which RNAP pauses during transcription of the leader (20) . It appears that the pausing of RNAP assists in the coupling of translation with transcription, and thus the overall efficiency of attenuation is increased as a result of the effect of the ribosome on leader RNA secondary structure.
The addition of exogenous ILV results in decreased expression of the ilvGMEDA operon (i.e., in some manner increases the efficiency of attenuation; Table 4 ). This could be achieved by any of the alterations in tRNA metabolism first described for the his operon (i.e., percent aminoacylation, quantity, or tRNA structure). One obvious option would be that the regulatory codons (i.e., ILV codons) for translation of the leader be rare or unusual (19) , because then a minor tRNA species or subset of tRNA could be either more completely aminoacylated or modified, reducing ribosome step time (i.e., increase the rate of translation) with a minimal effect on overall cellular metabolism. This is unlikely to be the entire explanation, because with the exception of one rare leucine codon (CUA), the leader region contains the more common ILV code words. However, a role for the single rare leucine codon in the regulation of the operon was demonstrated by Hsu et al. (17) and Harms and Umbarger (14) . The leader of E. coli has an adjacent pair of leucine codons (CUUCUA), while in Seratia marcescens there is a single CUA codon. Using biochemical and physiological studies, Hsu et al. (17) concluded that the single CUA codon affected expression of the S. marcescens operon. Harms and Umbarger (14) investigated the role of this codon by changing the CUA to the more common leucine codon CUG and to the proline codon CCG. Both of these changes resulted in reduced derepression of the operon when fully repressed cultures were compared with cultures growth-limited for leucine. While these studies demonstrate the role of this codon in derepression of the operon, they do not necessarily yield insight into the mechanism of repression.
Both theoretical (30, 46, 47) and experimental (20) analyses of the relationship between attenuation and changes in aminoacylation of tRNA indicate that relatively large changes (i.e., 40 to 50%) in the degree of aminoacylation would be required to achieve the five-to sevenfold modulation of gene expression observed upon the addition of ILV. Analysis of bulk ILV tRNA from E. coli K-12 growing on minimal medium indicates very high levels of aminoacylation. Unfortunately, the published determinations of the percent aminoacylation of isoleucyl-, leucyl-, and valyltRNAs isolated from different strains of E. coli grown in the absence or presence of ILV are sufficiently inconsistent to evaluate any relationship between repression, aminoacylation and attenuation (7, 12, 15-17, 39, 40, 49, 51) . Furthermore, the results obtained by Freundlich et al. (12) studying leucine tRNA make it doubtful that the measurement of the percent aminoacylation of bulk leucyl-, isoleucyl-, and valyltRNAs will yield insight into this process. As discussed, no change was observed in the rate of growth of E. coli K-12 (strain M152) upon the addition of ILV, which is also consistent with the idea that biosynthesis of these amino acids does not limit the growth of the bacteria. Thus, if the more abundant ILV tRNAs are altered, any major change in the rate of translation must be contextual (13, 44, 45) , occurring only over short segments of mRNA (i.e., in response to specific nucleotide sequences). Alternatively, the leader of the ilvGMEDA operon has an unusual secondary structure (25, 26, 35) which may be in part responsible for the observed regulation. Further understanding of the mechanism of regulation in response to an excess of ILV will require detailed mutational analysis of the leader and of the effect of exogenous ILV on the appropriate tRNA species. Careful analysis of those phenomena will increase our understanding of how the degree of attenuation or other translation-dependent termination events are modulated via the relative movements of RNAP and ribosomes through the leader.
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